Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/29/2012WO2012162416A1 Fatty acid amide hydrolase inhibitors for treating pain
11/29/2012WO2012162412A2 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012WO2012162409A1 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012WO2012162407A1 Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
11/29/2012WO2012162372A1 Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
11/29/2012WO2012162365A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
11/29/2012WO2012162364A1 Phenoxybenzamine for pain
11/29/2012WO2012162339A1 Use of teriflunomide for reducing occurrence of relapses requiring healthcare resources
11/29/2012WO2012162334A1 Compounds for the reduction of beta-amyloid production
11/29/2012WO2012162330A1 Tricyclic compounds as inhibitors for the production of beta-amyloid
11/29/2012WO2012162307A2 Crosslinked polymer nano-assemblies and uses thereof
11/29/2012WO2012162293A1 Combination therapy of hsp90 inhibitory compounds with mek inhibitors
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012162253A2 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012WO2012162249A1 Identification of compounds that disperse tdp-43 inclusions
11/29/2012WO2012162213A1 Aryloxymethyl cyclopropane derivatives as pde10 inhibitors
11/29/2012WO2012162211A2 Antisense oligonucleotides against neutral sphingomyelinase and neutral sphingomyelinase inhibitor gw4869 for degenerative neurological disorders
11/29/2012WO2012162127A1 Novel compounds as diacylglycerol acyltransferase inhibitors
11/29/2012WO2012162108A2 Boron-containing compositions and methods therefor
11/29/2012WO2012162054A1 Dynamic inhibitors of heat shock protein 90
11/29/2012WO2012162025A1 Methods of selecting cancer patients for treatment with n,n'-diarylurea compounds and n,n'-diarylthiourea compounds
11/29/2012WO2012162010A1 Expandable devices coated with a paclitaxel composition
11/29/2012WO2012162007A1 Expandable devices coated with a rapamycin composition
11/29/2012WO2012161965A1 Novel imidazole derivatives useful for the treatment of arthritis
11/29/2012WO2012161879A1 Thiazole derivatives
11/29/2012WO2012161877A1 Pyridine-and pyrazine derivatives
11/29/2012WO2012161812A1 Tricyclic inhibitors of kinases
11/29/2012WO2012161801A1 Anti-cancer nanoparticle compositions and methods of use
11/29/2012WO2012161799A1 Epidithiodioxopiperazines and uses thereof in treating cancer
11/29/2012WO2012161655A1 Composition and/or method for reducing and/or preventing myopia progression comprising atropine
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012161572A1 Composition comprising vitamin k2
11/29/2012WO2012161562A1 A process for producing nano-capsules and nano-beadlets containing phytonutrients derived from palm oil
11/29/2012WO2012161559A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
11/29/2012WO2012161558A1 Mixtures of acids for use as antiviral agents
11/29/2012WO2012161539A2 Sirna for inhibiting the expression of bhrf1 and composition comprising same
11/29/2012WO2012161520A2 Injectable liquid composition containing docetaxel
11/29/2012WO2012161518A2 Novel thiourea derivatives as activators of rorα and pharmaceutical composition containing same
11/29/2012WO2012161489A2 Patch containing rivastigmine
11/29/2012WO2012161448A1 Pharmaceutical composition for oral administration in form of suspension comprising revaprazan or its salt
11/29/2012WO2012161368A1 Preparation method of flumazenil labeled with fluorine-18 using diaryl iodonium salt precursor
11/29/2012WO2012161358A1 Pharmaceutical composition for preventing or treating attention deficit hyperactivity disorder (adhd), containing ginkgo leaf extract with enhanced terpenlactone
11/29/2012WO2012161301A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012WO2012161240A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012WO2012161173A1 Substituted amide compound
11/29/2012WO2012161124A1 Composition containing micro rna or expression system thereof
11/29/2012WO2012161119A1 Novel spiropiperidine derivative and pharmaceutical product containing same
11/29/2012WO2012160713A1 Learning and memory improver
11/29/2012WO2012160576A2 A process for preparation of meropenem
11/29/2012WO2012160568A1 Process for preparing docetaxel trihydrate polymorph
11/29/2012WO2012160559A1 Pharmaceutical compositions of d-alpha-tocopheryl acetate
11/29/2012WO2012160464A1 Heterocyclic compounds as protein kinase inhibitors
11/29/2012WO2012160447A1 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
11/29/2012WO2012160392A1 Morpholino compounds, uses and methods
11/29/2012WO2012160358A1 Cannabinoids for use in the treatment of neuropathic pain
11/29/2012WO2012160352A1 Pharmaceutical composition of rosuvastatin calcium
11/29/2012WO2012160337A1 Sulfated oligosaccharides for use in treatment of neurodegenerative diseases
11/29/2012WO2012160223A1 Pharmaceutical composition
11/29/2012WO2012160218A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012WO2012160188A1 Hydroxy-substituted amino and ammonium derivatives and their medical use
11/29/2012WO2012160187A1 Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160186A1 Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
11/29/2012WO2012160180A2 Pharmaceutical composition for administration to nails
11/29/2012WO2012160179A2 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012WO2012160130A1 Erk inhibitors for use in treating spinal muscular atrophy
11/29/2012WO2012160088A1 Bio-compatible nano and microparticles coated with stabilisers for pulmonary application
11/29/2012WO2012160085A1 Bio-compatible nano-polymer particles comprising active ingredients for pulmonary application
11/29/2012WO2012160080A1 Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
11/29/2012WO2012160051A2 Wet granulation methods of cetyl myristate and/or cetyl palmitate
11/29/2012WO2012160050A2 Particle size distribution of cetyl myristate and/or cetyl palmitate
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012160030A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/29/2012WO2012160029A1 Substituted triazolopyridines
11/29/2012WO2012160006A1 Antagonists of cb1 receptor.
11/29/2012WO2012159980A1 Novel strain of microalga that produces squalene
11/29/2012WO2012159964A1 Pharmaceutical composition comprising drotaverine
11/29/2012WO2012159962A1 Pharmaceutical composition comprising ketoprofen
11/29/2012WO2012159960A1 Pharmaceutical composition comprising fexofenadine
11/29/2012WO2012159959A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012WO2012159937A1 Compositions for the treatment of vaginal or rectal mucositis
11/29/2012WO2012159751A1 Hydrazidomycins
11/29/2012WO2012159666A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases
11/29/2012WO2012159662A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
11/29/2012WO2012159655A1 Shark-like chondroitin sulphate and process for the preparation thereof
11/29/2012WO2012159593A2 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation
11/29/2012WO2012159565A1 6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a] pyrimidine as hedgehog pathway inhibitor and use thereof
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012159552A1 Solid pharmaceutical composition containing benzimidazole derivative
11/29/2012WO2012159511A1 Azilsartan solid dispersion, preparation method and pharmaceutical compositions thereof
11/29/2012WO2012159457A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
11/29/2012WO2012159456A1 Cdc42 inhibitor and uses thereof
11/29/2012WO2012159446A1 METHOD FOR PRODUCING NATURAL β-CAROTENE BY FERMENTATION AND USE THEREOF
11/29/2012WO2012159444A1 Acupoint injection
11/29/2012WO2012159262A1 Selective glycosidase inhibitors and uses thereof
11/29/2012WO2012159237A1 Quick release-sustained release composition of compound methoxyphenamine
11/29/2012WO2012159215A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012WO2012142476A9 Methods and compositions for the treatment of marfan syndrome and associated disorders
11/29/2012WO2012140516A3 Non human animal model for ulcerative colitis and its main complications
11/29/2012WO2012139089A3 Fungal-derived carbohydrate-conjugated scaffold
1 ... 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 ... 7860